SCHEMBL15030524

SCHEMBL15030524

Cc1cccn(CC(=O)c2ccc(-c3ccncc3)cc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MAPT P10636 2/20 0.47
▸ MMP8 P22894 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ MMP14 P50281 1/20 0.44
▸ THRB P10828 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ CDC25A P30304 1/20 0.42
▸ CDC25B P30305 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ NOS1 P29475 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ STAT1 P42224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15030529 0.88 MKNK1 (0.48) ALDH1A1KDM4EMAPTMMP8MMP14
SCHEMBL16806629 0.83 KDM4E (0.54) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030297 0.82 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030298 0.82 RXFP1 (0.60) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030482 0.82 MEN1 (0.54) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030280 0.81 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030557 0.80 PLOD2 (0.47) ALDH1A1KDM4EMAPTMMP8MMP14
SCHEMBL15030485 0.78 MAPT (0.52) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030415 0.78 ALDH1A1 (0.56) ALDH1A1KDM4EMAPTTHRBRXFP1
SCHEMBL15030532 0.78 KDM4E (0.50) ALDH1A1KDM4EMAPTTHRBRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof KAKEN PHARMACEUTICAL CO., LTD. (JP) 2018-06-19 — — US disclosed
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof KAKEN PHARMACEUTICAL CO., LTD. (JP) 2018-06-19 — — US disclosed
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-11-24 — — US disclosed
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-11-24 — — US disclosed
US-9447072-B2 Pyridone derivative and pharmaceutical containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-09-20 — — US disclosed
US-9447072-B2 Pyridone derivative and pharmaceutical containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-09-20 — — US disclosed
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-06-16 — — US disclosed
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-06-16 — — US disclosed
EP-3006029-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION Kaken Pharmaceutical Co., Ltd. (JP) 2016-04-13 — — EP disclosed
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2015-06-18 — — US disclosed
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2015-06-18 — — US disclosed
WO-2013085017-A1 PYRIDONE DERIVATIVE AND MEDICINE CONTAINING SAME 科研製薬株式会社 (JP) 2013-06-13 — — WO disclosed
WO-2013085016-A1 PYRIDONE DERIVATIVE AND MEDICINE CONTAINING SAME 科研製薬株式会社 (JP) 2013-06-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340349-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME PLPBP, PDXK, PNPO ALDH1A1 327/4885KDM4E 1409/4885MAPT 2709/4885
US-10000476-B2 Pyridone derivative, pharmaceutical containing the same and methods of use thereof PNPO, PDXK, PLPBP ALDH1A1 368/4885KDM4E 1371/4885MAPT 3357/4885
US-20160168540-A1 COMPOSITION FOR MAINTAINING PLATELET FUNCTION PF4, F2, PFKP ALDH1A1 1362/4885KDM4E 4157/4885MAPT 4563/4885
US-20150166506-A1 PYRIDONE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME PLPBP, PDXK, PNPO ALDH1A1 327/4885KDM4E 1409/4885MAPT 2709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback